FDA Panel Rejects Use of MDMA for Treatment of PTSD
An independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.

Join our subscribers list to get the latest news, updates and special offers directly in your inbox
usnews Jul 4, 2024 0 227
usnews Jul 4, 2024 0 221
usnews Jul 4, 2024 0 219
usnews Jul 4, 2024 0 219
usnews Jul 4, 2024 0 218